Victoza
Novo’s Victoza beats Bydureon in head-to-head trial
March 4, 2011Research and Development, Sales and Marketing Alkermes, Amylin, Byureon, Victoza, diabetes, exenatide, lilly, type II diabetes
Bydureon has been outperformed by rival Victoza in a head-to-trial, decimating shares in its co-developer Amylin and Alkermes, the company …
Diabetes drugs show promise in Alzheimer’s
January 17, 2011Research and Development Alzheimer's, Alzheimer’s, Byetta, Novo Nordisk, Victoza, diabetes, exenatide, lilly, liraglutide
Research suggests that new diabetes drugs enhance cell growth in the brain, and could help treat Alzheimer’s disease. Researchers at …
Low dose Victoza on track for NICE approval
September 10, 2010Sales and Marketing NICE, Novo Nordisk, Victoza
Novo Nordisk is on track to receive NICE approval for its type II diabetes drug Victoza, but will still have …
Victoza wins partial NICE recommendation
June 15, 2010Sales and Marketing NICE, Victoza, diabetes
Novo Nordisk has been given a limited approval for its new type II diabetes treatment in draft guidance issued by …
Victoza claims head-to-head victory over Januvia
April 29, 2010Research and Development, Sales and Marketing Novo, Novo Nordisk, Victoza
Novo Nordisk says its diabetes treatment showed “significant” benefits over Merck’s rival Januvia in a head-to-head trial. Results published in …
FDA questions delay long-acting Byetta
March 17, 2010Manufacturing and Production Bydureon, Byetta, Syncria, Victoza
A once-weekly formulation of Eli Lilly and Amylin Pharmaceuticals’ blockbuster diabetes medication Byetta has hit a manufacturing hurdle en route …
Novo to challenge NICE Victoza guidance
February 15, 2010Sales and Marketing NICE, Novo Nordisk, Victoza
NICE has given a partial green light to Novo Nordisk’s type II diabetes treatment Victoza, backing its use as part …
Novo buoyed by insulin portfolio
February 2, 2010Sales and Marketing 2009 financials, Novo Nordisk, Victoza
Danish pharma company Novo Nordisk managed a double-digit rise in sales and profits in 2009, buoyed by insulin products NovoRapid, …
Pancreatitis concerns take shine off Victoza approval
January 28, 2010Sales and Marketing GLP-1, Novo Nordisk, Victoza
The FDA has approved Novo Nordisk’s Victoza a new once-daily injection for patients with type II diabetes. The drug will …
Victoza pill trial begins
January 19, 2010Research and Development, Sales and Marketing GLP-1, Novo Nordisk, Victoza, diabetes, type II
A promising new diabetes treatment which can be taken as a pill instead of as an injection has just begun …
Victoza launched in UK
July 9, 2009Sales and Marketing Victoza, diabetes
Novo Nordisk this week launched its much-anticipated type II diabetes treatment Victoza in the UK. Victoza (liraglutide) is the first …
Novo Nordisk plans summer launches for new diabetes drug
May 7, 2009Research and Development, Sales and Marketing Novo Nordisk, Victoza, diabetes
Novo Nordisk is preparing Victoza for a summer launch into its first European markets, including the UK, after it was …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
